BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Raggi F, Bosco MC. Targeting Mononuclear Phagocyte Receptors in Cancer Immunotherapy: New Perspectives of the Triggering Receptor Expressed on Myeloid Cells (TREM-1). Cancers (Basel) 2020;12:E1337. [PMID: 32456204 DOI: 10.3390/cancers12051337] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Thawani R, Kummar S. Combining PARP Inhibitor With Immunotherapy-Does the Promise of Preclinical Data Translate to Clinic? JAMA Oncol 2023;9:25-7. [PMID: 36394835 DOI: 10.1001/jamaoncol.2022.4591] [Reference Citation Analysis]
2 Indino S, Borzi C, Moscheni C, Sartori P, De Cecco L, Bernardo G, Le Noci V, Arnaboldi F, Triulzi T, Sozzi G, Tagliabue E, Sfondrini L, Gagliano N, Moro M, Sommariva M. The Educational Program of Macrophages toward a Hyperprogressive Disease-Related Phenotype Is Orchestrated by Tumor-Derived Extracellular Vesicles. Int J Mol Sci 2022;23. [PMID: 36555441 DOI: 10.3390/ijms232415802] [Reference Citation Analysis]
3 Muller M, Haghnejad V, Lopez A, Tiotiu A, Renaud S, Derive M, Bronowicki J. Triggering Receptors Expressed on Myeloid Cells 1 : Our New Partner in Human Oncology? Front Oncol 2022;12:927440. [DOI: 10.3389/fonc.2022.927440] [Reference Citation Analysis]
4 Xie Z, Li X, He Y, Wu S, Wang S, Sun J, He Y, Lun Y, Xin S, Zhang J. Analysis of the Prognostic Value and Potential Molecular Mechanisms of TREM-1 Overexpression in Papillary Thyroid Cancer via Bioinformatics Methods. Front Endocrinol (Lausanne) 2021;12:646793. [PMID: 34122331 DOI: 10.3389/fendo.2021.646793] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Chimal-eguia JC, Castillo-montiel E, Rangel-reyes JC, Paez-hernández RT. Modeling Dendritic Cell Pulsed Immunotherapy for Mice with Melanoma—Protocols for Success and Recurrence. Applied Sciences 2021;11:3199. [DOI: 10.3390/app11073199] [Reference Citation Analysis]
6 Wang L, Gao Y, Zhang G, Li D, Wang Z, Zhang J, Hermida LC, He L, Wang Z, Si J, Geng S, Ai R, Ning F, Cheng C, Deng H, Dimitrov DS, Sun Y, Huang Y, Wang D, Hu X, Wei Z, Wang W, Liao X. Enhancing KDM5A and TLR activity improves the response to immune checkpoint blockade. Sci Transl Med 2020;12:eaax2282. [DOI: 10.1126/scitranslmed.aax2282] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]